Skip to Main Content

Author Details

Sharon F McGee
The Ottawa Hospital Cancer Centre
2006
28
10
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36652284Web-Based Asynchronous Tool to Facilitate Communication Between Primary Care Providers and Cancer Specialists: Pragmatic Randomized Controlled Trial.J Med Internet Res2023
36975482Implementation of a Web-Based Communication System for Primary Care Providers and Cancer Specialists.Curr Oncol2023
37031968Pregnancy and neonatal outcomes following malignancy in pregnancy at a tertiary care Canadian center: a retrospective chart review.J Matern Fetal Neonatal Med2023
35112212Vasomotor symptoms in early breast cancer-a "real world" exploration of the patient experience.Support Care Cancer2022
35735438Evolving Role of Risk Tailored Therapy in Early Stage HER2-Positive Breast Cancer: A Canadian Perspective.Curr Oncol2022
36354722Patient and Healthcare Provider Perspectives on the Implementation of a Web-Based Clinical Communication System for Cancer: A Qualitative Study.Curr Oncol2022
35980464Delivery of cancer care via an outpatient telephone support line: a cross-sectional study of oncology nursing perspectives on quality and challenges.Support Care Cancer2022
32535678Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review.Support Care Cancer2021
33680749Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation.J Bone Oncol2021
33813329The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer.Cancer Treat Rev2021
33755864Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey.Breast Cancer Res Treat2021
34940066A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer.Curr Oncol2021
34023950Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey.Support Care Cancer2021
30318304Physician Survey of Timing of Adjuvant Endocrine Therapy Relative to Radiotherapy in Early Stage Breast Cancer Patients.Clin Breast Cancer2019
28666762The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.Clin Lung Cancer2018
30014951Optimal sequence of adjuvant endocrine and radiation therapy in early-stage breast cancer - A systematic review.Cancer Treat Rev2018
30111967Eastern Canadian Colorectal Cancer Consensus Conference 2017.Curr Oncol2018
24649821microRNAs: a new class of breast cancer biomarkers.Expert Rev Mol Diagn2014
24204025miRNA dysregulation in breast cancer.Cancer Res2013
22139072The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer.Oncogene2012
23060431miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro.Clin Cancer Res2012
20229355Synergistic interaction between trastuzumab and EGFR/HER-2 tyrosine kinase inhibitors in HER-2 positive breast cancer cells.Invest New Drugs2011
21999197Identification of a myometrial molecular profile for dystocic labor.BMC Pregnancy Childbirth2011
21677534SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.Am J Surg Pathol2011
19533747JAM-A expression positively correlates with poor prognosis in breast cancer patients.Int J Cancer2009
19826417Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment.Br J Cancer2009
17057642Mammary gland biology and breast cancer. Conference on Common Molecular Mechanisms of Mammary Gland Development and Breast Cancer Progression.EMBO Rep2006
23506067Functional interrogation of breast cancer: from models to drugs.Expert Opin Drug Discov2006
  • 1 - 28 of 28

Recommended Authors

Konstantinos Tryfonidis
Merck & Co., Inc.
Career Start Year 2011
Number of shared co-authors 0
Carmen Criscitiello
University of Milano
Career Start Year 2008
Number of shared co-authors 1
Shayna L Showalter
University of Virginia School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Catherine M Kelly
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 8
Kathryn J Ruddy
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 1
Larissa A Korde
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 0
Aditya Bardia
Massachusetts General Hospital Cancer Center
Career Start Year 2004
Number of shared co-authors 1
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 1
Matthew P Goetz
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 1
Peter A Fasching
Otto-Friedrich-University Bamberg
Career Start Year 2002
Number of shared co-authors 1
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 2
Sharon H Giordano
The University of Texas MD Anderson Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Fatima Cardoso
Champalimaud Clinical Center/Champalimaud Foundation
Career Start Year 2000
Number of shared co-authors 3
Ingrid A Mayer
Vanderbilt University Medical Center
Career Start Year 2000
Number of shared co-authors 0
Giuseppe Curigliano
University of Milan
Career Start Year 1996
Number of shared co-authors 4
Steven J Isakoff
Massachusetts General Hospital
Career Start Year 1995
Number of shared co-authors 0
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Career Start Year 1995
Number of shared co-authors 0
Abenaa M Brewster
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 0
Daniel Rea
Institute of Cancer and Genomic Sciences, The University of Birmingham
Career Start Year 1993
Number of shared co-authors 1
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 1
Ramona F Swaby
Merck & Co., Inc.
Career Start Year 1991
Number of shared co-authors 0
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 0
Caroline Seynaeve
Erasmus Medical Center
Career Start Year 1990
Number of shared co-authors 2
Clifford A Hudis
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Career Start Year 1987
Number of shared co-authors 0
Eric P Winer
Dana-Farber Cancer Institute
Career Start Year 1985
Number of shared co-authors 0
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 0
Kathleen I Pritchard
UCL Great Ormond Street Institute of Child Health, University College London
Career Start Year 1976
Number of shared co-authors 1
Larry Norton
Memorial Sloan Kettering Cancer Center
Career Start Year 1976
Number of shared co-authors 0
Gabriel N Hortobagyi
The University of Texas MD Anderson Cancer Center
Career Start Year 1976
Number of shared co-authors 0
James N Ingle
Mayo Clinic
Career Start Year 1952
Number of shared co-authors 0

Collaborators

William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers 9
Darran P O'Connor
UCD Conway Institute, University College Dublin
Co-authored papers 7
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Co-authored papers 6
Donal J Brennan
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Co-authored papers 5
Karin Jirstr??m
Lund University
Co-authored papers 4
Elton Rexhepaj
UCD Conway Institute, University College Dublin
Co-authored papers 3
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Co-authored papers 2
Rut Klinger
UCD Conway Institute, University College Dublin
Co-authored papers 2
Louis Banka Johnson
Skane University Hospital - Malmo, Lund University
Co-authored papers 1
Sami Kilpinen
University of Helsinki
Co-authored papers 1
Marcus Gry
AlbaNova University Center, KTH Royal Institute of Technology
Co-authored papers 1
Eric J T Belt
Albert Schweitzer Hospital
Co-authored papers 1
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers 1
Paul Wheatley-Price
The Ottawa Hospital Research Institute
Co-authored papers 1
Anna Asplund
Uppsala University
Co-authored papers 1
Caroline Kampf
Uppsala University
Co-authored papers 1
Kristina Magnusson
Uppsala University
Co-authored papers 1
Gerrit A Meijer
The Netherlands Cancer Institute
Co-authored papers 1
Helgi Birgisson
The Icelandic Cancer Registry
Co-authored papers 1
Kirsha Naicker
Co-authored papers 1
Stephen Welch
Victoria Hospital
Co-authored papers 1
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Jeroen A C M Goos
Karolinska Institutet
Co-authored papers 1
Aedin C Culhane
Dana-Farber Cancer Institute & Harvard School of Public Health
Co-authored papers 1
Olli Kallioniemi
Karolinska Institute
Co-authored papers 1
Kenneth Wester
Uppsala University
Co-authored papers 1
Sanjay Navani
Breach Candy Hospital and Research Centre
Co-authored papers 1
Carl A K Borrebaeck
Lund University
Co-authored papers 1
Khaled El Emam
CHEO Research Institute
Co-authored papers 1
Anders Bjartell
Skane University Hospital, Lund University
Co-authored papers 1
Release 1.2